Cytokinetics CYTK
NASDAQ CYTK
$55.23 +0.09 (+0.16%)
As of: Nov 10, 2026 · 12:59 PM EST

Cytokinetics (CYTK) Share-based Compensation (2010 - 2026)

Updated

Cytokinetics' Share-based Compensation was $34.72 million in Q3 2026, up 13.1% from $30.7 million a year earlier but down 2.8% from the prior quarter.

Analysis

Cytokinetics (CYTK) Share-based Compensation (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cytokinetics' Share-based Compensation was $131.33 million through Sep 30, 2026, up 21.6% year-over-year; for FY2025, it was $112.29 million, up 14.8% from FY2024.

  • Share-based Compensation has now increased for 11 consecutive years, with a five-year compound annual growth rate of 44.8% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $97.84 million in FY2024 (+35.8%), $72.07 million in FY2023 (+50.6%), $47.85 million in FY2022 (+78.3%) and $26.83 million in FY2021 (+52.3%).
  • Quarterly Share-based Compensation has moved between $6.71 million (Q4 2021) and $35.71 million (Q2 2026) over five years.
  • Compared with a year earlier, Share-based Compensation has increased for 30 straight quarters, with growth averaging 20.6% over the last eight quarters.
  • The year-over-year growth in Share-based Compensation has ranged between 9.0% (Q1 2025) and 100.5% (Q4 2022) over the last five years.
  • Per Business Quant data, CYTK's Share-based Compensation in the three quarters before Q3 2026 was $35.71 million (Q2 2026), $30.39 million (Q1 2026) and $30.51 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 357.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 160.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 234.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 362.00 Mn
10 Cytokinetics 7.81 Bn 3.81 Bn 47.10 Mn 34.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 34.72 Mn
Jun 30, 2026 35.71 Mn
Mar 31, 2026 30.39 Mn
Dec 31, 2025 30.51 Mn
Sep 30, 2025 30.70 Mn
Jun 30, 2025 27.54 Mn
Mar 31, 2025 23.55 Mn
Dec 31, 2024 26.25 Mn
Sep 30, 2024 25.36 Mn
Jun 30, 2024 24.62 Mn
Mar 31, 2024 21.61 Mn
Dec 31, 2023 19.49 Mn
Sep 30, 2023 18.72 Mn
Jun 30, 2023 18.67 Mn
Mar 31, 2023 15.20 Mn
Dec 31, 2022 13.45 Mn
Sep 30, 2022 13.20 Mn
Jun 30, 2022 12.20 Mn
Mar 31, 2022 9.00 Mn
Dec 31, 2021 6.71 Mn
API Access

Cytokinetics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CYTK&period=max&api_key=YOUR_API_KEY